» Articles » PMID: 32871405

Interactions of Particulate Matter and Pulmonary Surfactant: Implications for Human Health

Overview
Publisher Elsevier
Specialty Chemistry
Date 2020 Sep 2
PMID 32871405
Citations 32
Authors
Affiliations
Soon will be listed here.
Abstract

Particulate matter (PM), which is the primary contributor to air pollution, has become a pervasive global health threat. When PM enters into a respiratory tract, the first body tissues to be directly exposed are the cells of respiratory tissues and pulmonary surfactant. Pulmonary surfactant is a pivotal component to modulate surface tension of alveoli during respiration. Many studies have proved that PM would interact with pulmonary surfactant to affect the alveolar activity, and meanwhile, pulmonary surfactant would be adsorbed to the surface of PM to change the toxic effect of PM. This review focuses on recent studies of the interactions between micro/nanoparticles (synthesized and environmental particles) and pulmonary surfactant (natural surfactant and its models), as well as the health effects caused by PM through a few significant aspects, such as surface properties of PM, including size, surface charge, hydrophobicity, shape, chemical nature, etc. Moreover, in vitro and in vivo studies have shown that PM leads to oxidative stress, inflammatory response, fibrosis, and cancerization in living bodies. By providing a comprehensive picture of PM-surfactant interaction, this review will benefit both researchers for further studies and policy-makers for setting up more appropriate regulations to reduce the adverse effects of PM on public health.

Citing Articles

Force-bearing phagocytic adhesion rings mediate the phagocytosis of surface-bound particles.

Kundu S, Pal K, Pyne A, Wang X Nat Commun. 2025; 16(1):984.

PMID: 39856073 PMC: 11759950. DOI: 10.1038/s41467-025-56404-w.


Nanotechnology-based approaches for targeted drug delivery for the treatment of respiratory tract infections.

Georgakopoulou V, Papalexis P, Trakas N J Biol Methods. 2025; 11(4):e99010032.

PMID: 39839091 PMC: 11744063. DOI: 10.14440/jbm.2024.0065.


Individual and joint exposure to air pollutants and patterns of multiple chronic conditions.

Dai W, Xu W, Zhou J, Liu S, Zhou Q Sci Rep. 2024; 14(1):22733.

PMID: 39349744 PMC: 11443143. DOI: 10.1038/s41598-024-73485-7.


Polystyrene nanoplastics mediate oxidative stress, senescence, and apoptosis in a human alveolar epithelial cell line.

Milillo C, Aruffo E, Di Carlo P, Patruno A, Gatta M, Bruno A Front Public Health. 2024; 12:1385387.

PMID: 38799687 PMC: 11116779. DOI: 10.3389/fpubh.2024.1385387.


Cold waves and fine particulate matter in high-altitude Chinese cities: assessing their interactive impact on outpatient visits for respiratory disease.

Ning Z, He S, Liao X, Ma C, Wu J BMC Public Health. 2024; 24(1):1377.

PMID: 38778299 PMC: 11110372. DOI: 10.1186/s12889-024-18896-x.


References
1.
Kim Y, Krantz Q, McGee J, Kovalcik K, Duvall R, Willis R . Chemical composition and source apportionment of size fractionated particulate matter in Cleveland, Ohio, USA. Environ Pollut. 2016; 218:1180-1190. DOI: 10.1016/j.envpol.2016.08.073. View

2.
Andersson J, Roger K, Larsson M, Sparr E . The Impact of Nonequilibrium Conditions in Lung Surfactant: Structure and Composition Gradients in Multilamellar Films. ACS Cent Sci. 2018; 4(10):1315-1325. PMC: 6202641. DOI: 10.1021/acscentsci.8b00362. View

3.
Han X, Guo Q, Liu C, Fu P, Strauss H, Yang J . Using stable isotopes to trace sources and formation processes of sulfate aerosols from Beijing, China. Sci Rep. 2016; 6:29958. PMC: 4951693. DOI: 10.1038/srep29958. View

4.
Garcia-Mouton C, Hidalgo A, Cruz A, Perez-Gil J . The Lord of the Lungs: The essential role of pulmonary surfactant upon inhalation of nanoparticles. Eur J Pharm Biopharm. 2019; 144:230-243. DOI: 10.1016/j.ejpb.2019.09.020. View

5.
Rose D, Rendell J, Lee D, Nag K, Booth V . Molecular dynamics simulations of lung surfactant lipid monolayers. Biophys Chem. 2008; 138(3):67-77. DOI: 10.1016/j.bpc.2008.08.006. View